Digest Network Come funziona
Network
/
Società
Id
Non verificato

Idorsia Pharmaceuticals Ltd

Di cosa scriviamo

Annunci EconomiciFarmaceutica

79 comunicati stampa

Guarda tutti i comunicati
26/07/2026
Farmaceutica
Annunci Economici
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
23/07/2026
Farmaceutica
Annunci Economici
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
30/06/2026
Farmaceutica
Annunci Economici
Idorsia appoints Roland Wandeler as Chief Executive Officer
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
25/06/2026
Farmaceutica
Annunci Economici
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
08/06/2026
Farmaceutica
Annunci Economici
Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
31/05/2026
Farmaceutica
Annunci Economici
Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
31/05/2026
Farmaceutica
Annunci Economici
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
06/05/2026
Farmaceutica
Annunci Economici
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
27/04/2026
Farmaceutica
Annunci Economici
Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0
09/04/2026
Farmaceutica
Annunci Economici
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
Fonte
Idorsia Pharmaceuticals Ltd
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0